Research & Development

IMGENEX INDIA is committed to advancing biomedical research and innovation through a robust in-house Research & Development (R&D) program complemented by strategic collaborations with leading public and private research institutions, universities, hospitals, and industry partners. Our multidisciplinary research initiatives focus on translating scientific discoveries into novel diagnostics, therapeutics, and biotechnological solutions that address critical healthcare challenges.

Leveraging state-of-the-art technologies and collaborative expertise, IMGENEX INDIA has successfully executed numerous nationally funded research projects supported by agencies such as the Department of Biotechnology (DBT), BIRAC, Indian Council of Medical Research (ICMR), National Medicinal Plants Board (NMPB), and other Government of India initiatives.

Funded projects

The following projects highlight IMGENEX INDIA's sustained commitment to scientific excellence, innovation, and the development of impactful healthcare technologies through collaborative research and translational science.

  • Development of ScFv Against PCSK-9 Protein as an Alternative to Evolocumab as a Potent Drug Candidate for Familial Hypercholesterolemia/Hyperlipidemia. This project is funded by the Indian Council of Medical Research (ICMR), New Delhi.

  • Development and Validation of Multiplex Assays for Simultaneous Detection of SARS-CoV-2, Influenza A, Influenza B Antigens, and Respiratory Syncytial Virus (RSV). This project is carried out in collaboration with the ICMR National Institute of Health Research, Dibrugarh, and is funded by the Indian Council of Medical Research (ICMR), New Delhi.

  • Large Scale Production of SARS-CoV-2/COVID-19 Proteins and Development of Antibodies for Serological Tests. This project is funded by BIRAC, Department of Biotechnology (DBT), New Delhi.

  • Validation of Serological Diagnostic Reagents and Kits for Plant Viruses Affecting Horticultural Crops. This project is funded by BIRAC, Department of Biotechnology (DBT), New Delhi, in collaboration with the Indian Agricultural Research Institute (IARI), New Delhi.

  • Bio-Process Development for Production of Biosimilar Trastuzumab – Second Phase. This project is funded by BIRAC, Department of Biotechnology (DBT), New Delhi.

  • Development of a Diagnostic Kit for Detection of Mutations in Common Indian Beta-Thalassemia. This project was carried out in collaboration with the National Institute of Immunohematology, Mumbai, and funded by the Indian Council of Medical Research (ICMR), New Delhi.

  • Development of High Expression Plasmid Vectors for Production of Biosimilar Herceptin and Other Recombinant Proteins and Antibodies. This project was funded by the Department of Biotechnology (DBT) under the BIPP Scheme.

  • Development of Head and Neck Cancer Markers for a Diagnostic Array. This joint project was carried out in collaboration with All India Institute of Medical Sciences (AIIMS), New Delhi, York University, Toronto, Canada, and Xphase Pharmaceuticals Inc., Toronto, Canada.

  • Study on Iron(III) (Salen) and Iron(III) (Porphyrin) Complexes as Anti-Tumor Metallodrugs. This project was funded by the Department of Biotechnology (DBT), New Delhi, in collaboration with the National Institute of Science Education and Research (NISER), Bhubaneswar.

  • Studies on Toll-Like Receptor (TLR) Response in T Cells. This project was funded by the Department of Biotechnology (DBT), New Delhi, in collaboration with the National Institute of Science Education and Research (NISER), Bhubaneswar.

  • Phytochemical Analysis and Screening of Anticancer Compounds from Selected Medicinal Plant Species. This project was carried out in collaboration with the Regional Plant Resource Centre, Bhubaneswar, and funded by the National Medicinal Plants Board (NMPB), Ministry of Health and Family Welfare, Government of India.

  • Generation of Induced Pluripotent Stem (iPS) Cells from Adult Somatic Cells Using a Non-Genomic Protein Transduction Method. This project was jointly funded by IMGENEX India and the Department of Biotechnology (DBT) under the SBIRI Scheme.

  • Nanotechnology-Based Peptide Therapy for Osteoporosis. This project was jointly funded by IMGENEX India and the Department of Biotechnology (DBT) under the SBIRI Scheme, in collaboration with the Institute of Life Sciences, Bhubaneswar.